USFDA concludes inspection at Natco Pharma’s Kothur pharma division

20 Jun 2025 Evaluate

The U.S. Food and Drug Administration (USFDA) has concluded the inspection at Natco Pharma’s pharma division located in Kothur, Hyderabad, India. The said inspection was conducted from June 09 to June 19, 2025. 

On conclusion of the inspection, the Company received seven observations in the Form-483. The company remains committed to being cGMP compliant and in supplying high-quality products to its customers and patients globally.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

933.60 -15.25 (-1.61%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×